"SKiN Health offers Dermatological, Cosmetic Dermatology and Research services at two locations in Peterborough and Cobourg. The SKiN Dermatology offers a comprehensive range of diagnostic treatment and services for skin, hair and nails. Our team of certified medical professionals uses up-to-date equipment and has access to the latest research in the field. We are dedicated to providing the best experience in dermatological care. Our Research department is participating in various research trials relating to a number of skin conditions. Please visit our website for more information about our research trials."

During the past decade, SKiN Health conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SKiN Health" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Akros Pharma Inc." with 1 trials sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored and "Meiji Pharma USA Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SKiN Health" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SKiN Health" are "Atopic Dermatitis" (4 trials), "Psoriasis" (4 trials), "Plaque Psoriasis" (2 trials), "Hidradenitis Suppurativa" (1 trials) and "Skin Diseases" (1 trials). Many other conditions were trialed in "SKiN Health" in a lesser frequency.

Most popular intervention types in "SKiN Health" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lebrikizumab" (2 trials), "PF-06700841" (2 trials), "Vehicle (Placebo)" (2 trials) and "Core Treatment Active Experimental: SHR0302 Dose#1" (1 trials). Other intervention names were less common.

The vast majority of trials in "SKiN Health" are 10 trials for "All" genders.

Currently, there are NaN active trials in "SKiN Health". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in SKiN Health, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SKiN Health, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".